#1 Clinical Trials Search in Europe

Fosfomycin Trometamol

Fosfomycin Trometamol is an antibiotic medication that has been the subject of clinical trials for treating urinary tract infections (UTIs). These trials aim to evaluate its effectiveness, compare it to other treatments, and explore different dosing regimens. The studies focus on uncomplicated lower urinary tract infections in adult women, comparing Fosfomycin Trometamol to other antibiotics and even non-antibiotic alternatives.

Table of Contents

What is Fosfomycin Trometamol?

Fosfomycin Trometamol, also known by the brand name Monurol, is an antibiotic medication used to treat certain bacterial infections[1]. It is particularly effective against bacteria that cause urinary tract infections (UTIs). Fosfomycin Trometamol comes in the form of granules that are dissolved in water and taken orally[2].

What Conditions Does Fosfomycin Trometamol Treat?

Fosfomycin Trometamol is primarily used to treat uncomplicated lower urinary tract infections (LUTIs) in adult women[1]. These are infections that affect the bladder and urethra, causing symptoms such as:

  • Frequent urge to urinate
  • Burning sensation while urinating
  • Cloudy or strong-smelling urine
  • Lower abdominal discomfort

It’s important to note that Fosfomycin Trometamol is specifically designed for uncomplicated UTIs, which means infections in otherwise healthy individuals without underlying conditions that might complicate treatment[1].

How Does Fosfomycin Trometamol Work?

Fosfomycin Trometamol works by killing the bacteria that cause urinary tract infections. It does this by interfering with the bacteria’s ability to form cell walls, which are essential for their survival. Without proper cell walls, the bacteria die, and the infection clears[1].

How is Fosfomycin Trometamol Administered?

The dosage and administration of Fosfomycin Trometamol can vary depending on the specific treatment regimen. Based on the clinical trials described, there are two main approaches:

  1. Single-dose treatment: A single 3g dose of Fosfomycin Trometamol, taken orally as a sachet of granules dissolved in water[1].
  2. Short-course treatment: 3g of Fosfomycin Trometamol taken once daily for two days[1].

In another study, a single dose of 8g of Fosfomycin Trometamol granules was used[2]. The exact dosage should always be determined by your healthcare provider based on your specific condition and needs.

Effectiveness of Fosfomycin Trometamol

The effectiveness of Fosfomycin Trometamol is measured in clinical trials by two main factors:

  1. Clinical effectiveness: This is defined as the resolution of UTI symptoms, typically assessed about a week after treatment[1].
  2. Bacteriological eradication: This refers to the elimination of the bacteria causing the infection, usually measured by a urine culture test about two weeks after treatment[1].

Clinical trials are ongoing to determine the exact rates of effectiveness, but Fosfomycin Trometamol has been shown to be an effective treatment for uncomplicated UTIs in many cases[1][2].

Comparison with Other Treatments

Fosfomycin Trometamol is being compared to other antibiotic treatments for UTIs in clinical trials. Some of these alternatives include:

  • Pivmecillinam: Taken as 400 mg pills, three times a day for three days[1].
  • Nitrofurantoin: Taken as 100 mg pills, three times a day for five days[1].

Interestingly, Fosfomycin Trometamol is also being compared to non-antibiotic treatments. One study is comparing it to a herbal drug containing centaury, lovage root, and rosemary leaf (CLR)[2]. This comparison aims to find alternatives to antibiotic treatment, which could help reduce the development of antibiotic resistance.

Potential Side Effects

As with any medication, Fosfomycin Trometamol may cause side effects. Clinical trials are monitoring for adverse events, which can range from mild to severe[1]. Common side effects of antibiotics can include:

  • Nausea or vomiting
  • Diarrhea
  • Headache
  • Rash or itching

It’s important to report any unusual symptoms to your healthcare provider. They will be able to determine if these are related to the medication and advise on the best course of action.

Aspect Details
Main Focus Treatment of uncomplicated lower urinary tract infections in adult women
Fosfomycin Trometamol Dosing Single 3g dose, Two 3g doses over two days, Single 8g dose of granules
Comparison Treatments Nitrofurantoin, Pivmecillinam, CLR (herbal drug)
Primary Outcomes Clinical effectiveness, Bacteriological eradication, Need for additional antibiotics
Secondary Outcomes Duration of symptoms, Relapse rates, Adverse events, Quality of life changes
Trial Designs Randomized, multicenter, parallel group, some double-blind
Significance Exploring antibiotic alternatives, Reducing antibiotic resistance, Improving UTI treatment options

FAQ

  • What is Fosfomycin Trometamol used for in these clinical trials? Fosfomycin Trometamol is being studied for the treatment of uncomplicated lower urinary tract infections (UTIs) in adult women.
  • How is Fosfomycin Trometamol administered in these trials? In the trials, Fosfomycin Trometamol is administered orally in different regimens, including a single 3g dose, two 3g doses taken once daily for two days, or as a single 8g dose of granules.
  • What are the main outcomes being measured in these trials? The main outcomes include clinical effectiveness (resolution of symptoms), bacteriological eradication (reduction of bacteria in urine), and the need for additional antibiotic treatment.
  • How does Fosfomycin Trometamol compare to other treatments in these trials? The trials compare Fosfomycin Trometamol to other antibiotics like nitrofurantoin and pivmecillinam, as well as to a non-antibiotic herbal treatment called CLR (containing Centaury, Lovage Root, and Rosemary Leaf).
  • Why are these clinical trials important? These trials are important because they aim to find effective treatments for UTIs while potentially reducing antibiotic use and the development of antibiotic resistance. They also explore alternative treatments and different dosing regimens to improve patient care.

Ongoing Clinical Trials on Fosfomycin Trometamol

  • Study on Fecal Microbiota Transfer for Preventing Recurrent Urinary Tract Infections in Premenopausal Women Using Intestifix

    Recruiting

    1 1
    Investigated drugs:
    Germany

  • Testing Antibiotic Treatment Strategies for Patients with Bladder Bacteria Without Symptoms Receiving Botulinum Toxin A Bladder Injections

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of methenamine hippurate compared to a drug combination for preventing recurrent urinary tract infections in women

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • A study of fosfomycin trometamol treatment for male urinary tract infections in primary care settings

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    France

Glossary

  • Uncomplicated lower urinary tract infection (LUTI): A common infection affecting the bladder and urethra, typically in women with no other health issues or abnormalities in their urinary system.
  • Fosfomycin Trometamol: An antibiotic medication used to treat urinary tract infections, also known by the brand name Monurol.
  • Bacteriological eradication: The elimination or significant reduction of bacteria causing an infection, usually measured by laboratory tests.
  • Colony forming units (cfu): A measure used to estimate the number of viable bacteria in a sample.
  • Antibiogram: A report showing the sensitivity of bacteria to different antibiotics, used to guide treatment choices.
  • Pyelonephritis: A serious kidney infection that can occur as a complication of an untreated urinary tract infection.
  • Urosepsis: A life-threatening condition where an infection in the urinary tract spreads to the bloodstream.
  • EQ-5D-5L: A standardized questionnaire used to measure health-related quality of life.
  • Non-inferiority trial: A type of clinical trial designed to show that a new treatment is not worse than an existing treatment by more than a pre-specified margin.
  • CLR: A herbal drug containing Centaury, Lovage Root, and Rosemary Leaf, being studied as a non-antibiotic treatment for urinary tract infections.

References

  1. https://clinicaltrials.gov/study/NCT04959331
  2. https://clinicaltrials.gov/study/NCT02639520